Cholera deaths during outbreaks in Uvira, Eastern Democratic Republic of Congo, September 2021-January 2023

Patrick Musole Bugeme,Hanmeng Xu, Chloe Hutchins,Juan Dent Hulse,Jaime Mufitini Saidi,Baron Bashige Rumedeka, Moise Itongwa, Justin Bengehya, Jean-Claude Kulondwa,Amanda K Debes,Iza Ciglenecki, Esperance Tshiwedi, Faida Kitoga, Tavia Bodisa-Matamu,Nadege Taty,Hugo Kavunga-Membo,Jackie Knee,Placide Okitayemba Welo,Daniel Mukadi-Bamuleka,Andrew Azman,Espoir Bwenge Malembaka

medRxiv (Cold Spring Harbor Laboratory)(2023)

引用 2|浏览4
暂无评分
摘要
Our understanding of the burden and drivers of cholera mortality is hampered by limited surveillance and confirmation capacity. Leveraging enhanced clinical and laboratory surveillance in the cholera-endemic community of Uvira, eastern Democratic Republic of Congo, we describe cholera deaths across two seasonal outbreaks between September 2021-January 2023, following mass vaccination. ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement This work was supported by the Wellcome Trust and Gavi (GAVI-RFP-2019-062). ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Ethical approvals were obtained from Institutional Review Boards of the Johns Hopkins Bloomberg School of Public Health (IRB00015785), The London School of Hygiene and Tropical Medicine (25365) and the Ecole de Sante Publique at the University of Kinshasa (ESP/CE/65/2021). I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes All data produced in the present work are contained in the manuscript.
更多
查看译文
关键词
congo,outbreaks,uvira
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要